Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

(APhA) Pharmacy-Based Cardiovascular Disease Risk Management


APhA’s Pharmacy-Based Cardiovascular Disease Risk Management is an innovative and interactive certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.

 

The goals of this program are to: 

  • Educate pharmacists on current evidence-based treatment goals and clinical management recommendations for dyslipidemia and hypertension.
  • Familiarize pharmacists with important concepts related to healthful lifestyle changes that focus on cardiovascular disease prevention.
  • Introduce techniques and skills for encouraging patient adherence to prescribed therapies.
  • Ensure pharmacist proficiency in blood pressure measurement technique and point-of-care lipid testing.
  • Enhance pharmacist experience in applying elements of motivational interviewing with respect to medication adherence and lifestyle modifications.

APhA’s Pharmacy-Based Cardiovascular Disease Risk Management certificate training program has two components: web-based interactive self-study with assessment and the live seminar with online final assessment. A Certificate of Achievement will be awarded to participants who successfully complete all program components, including an evaluation.

Live Training Seminar will focus on these core areas: 

  • A case-based approach to cardiovascular disease risk assessment and treatment decisions, managing special situations, treating hypertension in a patient with diabetes, and lifestyle modifications and motivational interviewing.
  • Skills assessments on blood pressure measurement technique and motivational interviewing. Participants will be conducting blood pressure assessments on other participants.
  • A discussion regarding the role of the pharmacist and existing business models for cardiovascular disease risk management services.

 For a complete list of learning objectives and for all APhA accreditation information and policies, please visit APhA’s website, http://www.pharmacist.com/pharmacy-based-cardiovascular-disease-risk-management.

 

Seminar Agenda: 

  • Welcome and Introductions
  • Cardiovascular Disease Risk Assessment and Treatment Decisions
  • Aspirin for Primary Prevention of ASCVD Events
  • Break (15 min)
  • Special Considerations for Management of Hypertension and Lipids in Patients with Chronic Kidney Disease or Advanced Age
  • Treatment Decisions for Patients with Borderline Risk
  • Managing Risks of Statin Therapy
  • Hospital Readmissions
  • Lifestyle Modifications
  • Lunch and Networking (30 minutes)
  • Motivational Interviewing
  • Motivational Interviewing Activity
  • Patient Assessment Skills
  • Blood Pressure Measurement Practice
  • Break (15 min)
  • Business Considerations and Practice Models
  • Transitions of Care Patient Case
  • Take Home Points, Questions, and Final Instructions
  • Adjournment

PROGRAM FEE

UNTIL 10/01/2017

AFTER 10/01/2017

AzPA Member Pharmacist

$350

$400

Non-Member Pharmacist

$450

$500

AzPA Member Student

$250

$300

Non-Member Student

$300

$350

 

 

 

 

 

 

 

 

 

Save $50 if you register before October 1st. Use Coupon Code: Cardio17 

 

Continuing Pharmacy Education (CPE) Information and Activity Completion Requirements:

Initial release date: 02/20/2015; expiration date:  02/20/2018

Activity Type:  Practice-based

Learning Level: 2 — Experience with the topic is recommended, but advanced expertise or specialty practice in the subject area is not necessary. This activity will focus on expanding the learner’s knowledge and application of new and/or more complex information.

Target Audience:  Pharmacists in all practice settings 

  • Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 12 contact hours of CPE credits (1.2 CEUs). ACPE Universal Activity Number: 0202-9999-15-001-H04-P
  • Successful completion of the live seminar component involves attending the full live seminar, passing the final assessment with a grade of 70% or higher and completing a skills assessment. Successful completion of this component will result in 8 contact hours of CPE credit (0.80 CEU).    ACPE Universal Activity Number: 0202-9999-15-002-L04-P 

Once credit is claimed, Statements of Credit will be available online within 24 hours on participant’s CPE Monitor profile at www.nabp.net. The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s “My Training” page on www.pharmacist.com

 

Activity Completion Requirements

A Certificate of Achievement is awarded to participants who successfully complete all activity requirements, which include a pre-test, the self-study activity, the self-study assessment, the live training seminar, and the final assessment. Successful completion is defined as completing the pre-test, a self-study assessment score of 70% or higher, attendance at the live seminar, a final assessment score of 70%, and completion of the activity evaluation.

 

The American Pharmacists Association and the Arizona Pharmacy Association are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Activity Requirements -  Course material and exams will be accessed online - In order to participate in this activity, registrants must have access to a computer with minimum system requirements:  Internet connectivity with current version of internet browsers, such as Chrome, Firefox, Safari, or Internet Explorer (V8 and above); Adobe Acrobat Reader, Flash Player 8 or higher, Windows 95, Pentium 3 or equivalent processor, 64 MB of free memory (not 64 MB total), and Audio: Sound card and speakers or earphones.  For full technology requirements, please visit http://www.pharmacist.com/pharmacy-based-immunization-delivery

 

APhA’s Pharmacy-Based Cardiovascular Disease Risk Management  was developed by the American Pharmacists Association.

 

Refund Policy:

Refund and/or cancellation requests must be made in writing to the Arizona Pharmacy Association office. A cancellation request must be made at last fourteen calendar days prior to the scheduled program and will require a $175.00 fee. No refunds will be issued for cancellation requests made less than fourteen calendar days prior to the scheduled program. You must submit a written request to cancel by email, fax, or standard mail and confirm that AzPA has received the request. AzPA reserves the right to cancel any activity due to insufficient pre-registration or as determined by the Executive Director or CE Administrator. In this case, all individuals pre-registered are notified and issued a fill refund. Registration fees cannot be re-allocated due to the multiple steps involved with processing CE Credits. Refund checks will be mailed fourteen business days after the conclusion of the meeting, if approved. For more information about refunds and/or cancellation requests please contact the Operations Director.

 

 

Date: Oct 28, 2017 08:00 AM - 05:00 AM

Registration closes on Oct 27, 2017 12:00 AM

Target Audience(s)

  • Pharmacists

 

 

Registration closes on Oct 27, 2017 at 12:00 AM

Registration Closed  

Registration Closed